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INTRODUCTION:  Primary  adenocarcinoma  of  the  4th  portion  of  the  duodenum  is reported  less  frequently
than  those  other  portions  of the duodenum.  Therefore,  few reports  discuss  the  diagnosis  and  treatment
of  this  malignancy.
PRESENTATION  OF  CASE:  A 54-year-old  woman  was  admitted  to  our hospital  with  a complaint  of nausea
and  vomiting  after a meal.  Upper  gastrointestinal  examination  and  a duodenogram  revealed  a  Type  2
tumor  of  the  4th  portion  of  the  duodenum,  which  was  diagnosed  as  well-differentiated  tubular  adeno-
carcinoma  by endoscopic  biopsy.  Partial  resection  of the  duodenum  and  jejunum  was performed  on  the
basis  of  intraoperative  evaluation  of negative  lymph  node  metastasis  around  the pancreas  and  proxi-
mal  duodenum  with  no macroscopic  invasion  toward  the  pancreas  and  proximal  duodenal  margin.  Her
postoperative  course  was  uneventful  without  any  sign  of  recurrence  5 years  later.
DISCUSSION: Primary  adenocarcinoma  in  the  4th  portion  is relatively  less  common.  It  is not  easy  to
diagnose  this  disease.  Patients  with  primary  duodenal  adenocaricinoma,  who  are  medically  ﬁt  to  undergo
surgery,  should  be  given  the  option  of aggressive  resection.  Duodeno-cephalo-pancreatectomy  remains
the  standard  treatment  for  adenocarcinomas  of the 1st  and  2nd  portion  of  the  duodenum.  Partial  resection
is  the  preferred  surgical  method  for patients  with  adenocarcinoma  of  the  3rd  and 4th  portions  of  the
duodenum.
CONCLUSION:  This  report  describes  a rare  case  of  primary  adenocarcinoma  of  the  4th  portion  of  the
duodenum,  successfully  treated  by partial  resection  of  the  duodenum  and  jejunum.  However,  larger
studies  are  required  to  clarify  the  indications  for  the  preferred  surgical  method  for  this  malignancy.
gical © 2013 Sur
. Introduction
Primary adenocarcinoma of the 4th portion of the duodenum
s reported less frequently than other portions of the duodenum.
herefore, few reports discuss this malignancy. The diagnosis of pri-
ary adenocarcinoma of duodenum (PDA) is often delayed because
ts symptoms and signs are nonspeciﬁc.1 Furthermore, it is not
asy to make a diagnosis in the 4th portion of the duodenum.
lthough, endoscopic treatment has been attempted for early duo-
enum cancer, surgical treatment should be indicated for more
dvanced disease.2,3 Here, we report a PDA case of the 4th portion
f the duodenum, and relevant literature has been discussed and
eviewed.
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2. Presentation of case
A  57-year-old woman was admitted to our hospital with a
complaint of vomiting after a meal. She had been experiencing nau-
sea following eating since the last 2 months. On admission, the
patient was  153 cm tall and weighed 46.2 kg. A physical examina-
tion revealed no abdominal mass or tenderness. Her blood pressure
was 118/71 mmHg, and her heart rate was 64 bpm. Blood exam-
ination revealed a white blood cell count of 9900/mm3 and a
hemoglobin concentration of 12.5 g/dl. Her total bilirubin and fas-
ting blood sugar levels were 0.65 mg/dl and 126 mg/dl, respectively.
The levels of tumor markers CEA, CA19-9, and AFP were 1.9 ng/ml,
14.8 U/ml, and 2.2 ng/ml, respectively.
Upper  gastrointestinal endoscopy revealed a Type 2 tumor with
stenosis at the distal portion of the papilla of Vater (Fig. 1), and the
endoscopic biopsy specimen showed a well-differentiated tubular
adenocarcinoma of the duodenum. The duodenogram revealed a
Open access under CC BY-NC-ND license. Type 2 tumor at the 4th portion of the duodenum (Fig. 2). Com-
puted tomography of the abdomen revealed an irregular thick wall
of the 4th portion of the duodenum and no lymph nodes swollen
intra-abdominal cavity (Fig. 3). The patient underwent surgery.
NC-ND license. 
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Fig. 1. Upper gastrointestinal endoscopy showing a Type 2 tumor around the cir-
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numference with stenosis at distal portion of the papilla of Vater. Endoscopic biopsy
pecimen showing a well-differentiated tubular adenocarcinoma of the duodenum.
aparotomy did not reveal direct invasion into the pancreas, perit-
neal dissemination, or distant metastasis. However, macroscopic
xamination revealed tumor extension through serosal inﬁltra-
ion. Rapid histological diagnosis during surgery showed no lymph
ode metastasis around the pancreas. Partial resection of the
uodenum and jejunum accompanied with lymph node dissec-
ion along the superior mesenteric artery was performed. The
nferior pancreaticoduodenal artery and 1st jejunal artery were
igated for lymphadenectomy. Histological examination showed
ell-differentiated tubular adenocarcinoma partially comprising
ucinous adenocarcinoma (Fig. 4) and no lymph node metastasis
icroscopically. The deﬁnitive diagnosis was primary adenocar-
inoma of the 4th portion of the duodenum, T4N0M0, Stage II
ccording to the TNM classiﬁcation of malignant tumors (American
oint committee on Cancer). Postoperative upper gastrointestinal
nvestigation did not show stenosis or leakage. The anastmosis
hat had obstructed the passage functionally had conservatively
mproved. The patient started a diet on POD 18 and left the hospital
ig. 2. The duodenogram showing a Type 2 tumor of the 4th portion of the duode-
um.Fig. 3. Abdominal computed tomography scan showing an irregularly thick wall of
the 4th portion of the duodenum. No lymph nodes were found around the pancreas,
superior  mesenteric artery, or the aorta.
on POD 34. Her postoperative course was  uneventful, and she is
without any sign of recurrence 5 years later.
3. Discussion
Primary adenocarcinoma of the duodenum (PDA) is a rare
malignant tumor, accounting for 0.3–0.5% of all gastroenteral
malignancies.4,5 Approximately 30–50% small intestinal adeno-
carcinomas occur in the duodenum.6–8 Studies show that 1–15%
tumors are located in the 1st portion, 50–75% in the 2nd portion,
14–33% in the 3rd portion, and 5–17% in the 4th portion of the
duodenum.9–11 Primary adenocarcinoma in the 2nd portion of the
duodenum is most common, whereas that in the 4th portion is rela-
tively less common. There is an average delay of 2–15 months from
the onset of symptoms to the time of diagnosis of PDA.12 Upper
gastrointestinal endoscopy screening cannot reveal the disease
within the horizontal and ascending portions. Examining the entire
duodenum using upper gastrointestinal endoscopy is challenging;
adenocarcinomas of the 3rd and 4th portions of the duodenum are
frequently inaccessible using endoscopy, and most cases require
multiple investigations.13 In fact, the 1st endoscopic examination
in our patient could not identify the duodenal tumor. A deﬁni-
tive diagnosis of adenocarcinoma was  made 2 months after the
onset of her symptoms. However, new modalities such as double-
balloon enteroscopy or capsule endoscopy can make diagnosis of
small bowel or duodenal adenocarcinoma easier.1,14
Some studies have reported that lymph node status, pancreas
invasion, duodenum invasion, and tumor size are predicators of
prognosis for survival in patients with duodenal adenocarcinoma
who underwent surgery.15–18 In contrast, some other studies have
reported that tumor size, tumor location within the duodenum,
depth of partial penetration, local nodal metastases, tumor dif-
ferentiation, and invasion of the pancreas were not predictive of
prognosis.10,12 There were no clear relationship between tumor
differentiation and outcome.2,10,12
Some papers have reported that radical resection offers good
long-term results for locally advanced duodenal adenocarcinoma.
Resected patients and nonresected patients with PDA had 5-year
survival rates of 25–75% and 0% respectively.12,15,19 Five-year sur-
vival rates for T4 stage and non-T4 stage patients with PDA were
20% and 40%, respectively.2 It was  reported a ﬁve-year survival rates
in stage I and II of 100% and 52% respectively and 45% and 0% at stage
III and IV, respectively.19 It has been reported that life expectancy
after resection of the 1st and 2nd portion of the duodenum is longer
than that after resection of the 3rd and 4th portions. The median
survival time after resection of the 1st and 2nd portions of the duo-
denum and after resection of the 3rd and 4th portions were 30
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Fig. 4. (A) The resected specimen showing a Type 2 tumor at the 4th portion of
the duodenum, measuring 50 mm × 45 mm in size. (B) Histological ﬁndings of the
resected specimen showing a well-differentiated tubular adenocarcinoma (Hemo-
toxylin Eosin stain, magniﬁcation 20×). (C) Histological ﬁndings of the resected
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neoplasms: histopathologic determinants of recurrence and survival. Annals ofpecimen  showing a well-differentiated tubular adenocarcinoma (Hemotoxylin
osin  stain, magniﬁcation 100×).
onths and 46 months, respectively.13 Five-year survival rate for
esection of the 3rd and 4th portions of the duodenum was 58%,
hereas that of 1st and 4th portions was 32%.16
Early stage duodenal carcinoma should be considered for endo-
copic mucosal resection. Advanced stages of PDA require surgical
esection for a cure. Patients with PDA, who  are medically ﬁt
o undergo surgery, should be given the option of aggressive
esection.2 Duodeno-cephalo-pancreatectomy (DCP) and segmen-
al resection of the duodenum are employed for treating PDA.20 DCP
emains the standard treatment for adenocarcinomas of the 1st and
nd portion of the duodenum. Patients with locally advanced (N1)
umors (Stage III) can beneﬁt from this aggressive approach with
ood long-term results.15 Some studies have reported good survivalPEN  ACCESS
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results  following segmental duodenectomy despite limited lymph
adenectomy occurring during surgical procedure and considerably
lower postoperative morbidity.13,16 Segmental duodenectomy is
the preferred resection method for patients with adenocarcinoma
of the 3rd and 4th portions of the duodenum.13 Our patient had a
T4 stage well-differentiated tubular adenocarcinoma without his-
tological lymph node metastases around the pancreas head and
no macroscopic invasion of the pancreas or surgical margin. We
decided to treat our patient with partial resection of the duodenum
and jejunum, and she is doing well without any sign of recurrence
ﬁve years later.
4.  Conclusion
PDA of the 4th potion is rare, and studies have reported this can-
cer in a small number of patients. The indications for the preferred
surgical method require to be clariﬁed by larger studies. This report
describes a case of primary adenocarcinoma of the 4th portion
of the duodenum, successfully treated by partial resection of the
duodenum and jejunum.
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